<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00364949</url>
  </required_header>
  <id_info>
    <org_study_id>P50HD044405</org_study_id>
    <nct_id>NCT00364949</nct_id>
  </id_info>
  <brief_title>Intrauterine Environment in Polycystic Ovary Syndrome (PCOS) Probands</brief_title>
  <official_title>Genes, Androgens and Intrauterine Environment in PCOS</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)</source>
  <brief_summary>
    <textblock>
      Polycystic ovary syndrome (PCOS) is among the most common endocrine disorders in
      premenopausal women, affecting 7-10% of this population. This syndrome is characterized by
      elevated levels of testosterone and chronic anovulation, and frequently of obesity. This
      study is designed to test the hypothesis that there is in utero testosterone excess, altered
      insulin secretion, and/or intrauterine growth retardation in the female offspring of women
      with PCOS. The allele 8 can be used to identify the reproductive and metabolic abnormalities
      associated with PCOS. This study will determine whether allele 8 positive [A8(+)] female
      offspring have more profound changes in these parameters compared to A8(-) female offspring.

      Androgen and insulin levels in amniotic fluid from pregnant women with PCOS will be compared
      to levels in pregnant control women. Androgen and insulin levels in cord blood will also be
      measured. Further, gestational age and anthropomorphic measurements in offspring of women
      with PCOS will be assessed and compared to that in offspring of matched control women.

      We will test the hypothesis that androgens are elevated in infancy in the female offspring of
      women with PCOS. We will assess sex steroids, insulin, and c-peptide levels in infants of
      PCOS women and compare them to the levels in infants of control women up to 1 year of age
      during the minipuberty of infancy. We will determine whether any of these parameters differ
      in A8(+) compared to A8(-) PCOS offspring.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      BACKGROUND Polycystic ovary syndrome (PCOS) is among the most common endocrine disorders in
      premenopausal women, affecting 7-10% of this population. This syndrome is characterized by
      hyperandrogenism, chronic anovulation and, frequently, obesity. Hyperandrogenemia seems to be
      a consistent reproductive phenotype in male relatives as well as female relatives of PCOS
      women. This phenotype appears to have a genetic basis in PCOS families and shows significant
      linkage and association with a marker locus on chromosome 19p in the region of the insulin
      receptor (allele 8 of D19S884.). This allele is also recently found to be associated with a
      metabolic phenotype in PCOS probands and their brothers, including increased post-challenge
      glucose levels, apparent defects in insulin secretion, especially in response to
      sulfonylurea, and accelerated weight gain with age (unpublished date). Therefore, allele 8
      status in PCOS probands and their family members can identify the reproductive and metabolic
      abnormalities.

      Many epidemiologic studies showed a plausible link between low birth weight and chronic
      metabolic disorders manifested as hypertension, diabetes and obesity later in life,
      suggestive of an early fetal programming. There is evidence to support fetal origin of PCOS.
      Female rhesus monkeys that were exposed to excess androgen in utero, were born smaller for
      gestational age. These animals had many of the reproductive features of PCOS, including
      increased LH levels, irregular ovulation, polycystic ovaries and functional ovarian
      hyperandrogenism. Similarly, in retrospective cohort studies, girls with elevated adrenal
      androgen levels or with PCOS were significantly smaller for gestational age at birth than
      reproductively normal control girls, suggestive of a possible fetal origin for some features
      of PCOS in human studies. Molecular mechanism for fetal programming is not clearly
      understood, but permanent changes in gene expression caused early insult may be a factor.

      HYPOTHESIS These observations have led to a new hypothesis for the etiology of PCOS; genetic
      variation resulting in hyperandrogenemia leads to many of the reproductive and metabolic
      features of PCOS later in life. We will directly test the hypothesis that there is an excess
      androgen production in female offspring of women with PCOS. Further, we will test whether
      A8(+) female offspring have more profound changes in these parameters (increased androgen
      and/or decreased insulin levels in fetal life and in infancy) compared to A8(-) female
      offspring.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2003</start_date>
  <completion_date type="Actual">July 2012</completion_date>
  <primary_completion_date type="Actual">July 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Estradiol Level in Female Offspring</measure>
    <time_frame>One time sampling from the cord blood</time_frame>
    <description>The blood that were analyzed were taken from cord blood and not from the offspring.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Androstenedione Level in Female Offspring</measure>
    <time_frame>cord blood</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Testosterone Level in Female Offspring</measure>
    <time_frame>cord blood</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>17-hydroxyprogesterone Level in Female Offspring</measure>
    <time_frame>cord blood</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Dihydrotestosterone Level in Female Offspring</measure>
    <time_frame>cord blood</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Dehydroepiandrosterone Level in Female Offspring</measure>
    <time_frame>cord blood</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Infant Birth Weight (Male and Female)</measure>
    <time_frame>birth</time_frame>
  </primary_outcome>
  <enrollment type="Actual">70</enrollment>
  <condition>Polycystic Ovary Syndrome</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Women with PCOS and control women and their offspring
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Probands who meet the following criteria will be enrolled:

        Menses &lt; 6 per year without confounding meds Not taking confounding medications at the time
        of hormone analysis, willing to be off confounding medications for required washout period,
        or able to provide documentation of hyperandrogenemia (without hyperprolactinemia or
        evidence of non-classical adrenal hyperplasia) with past laboratory tests during a time
        when not taking confounding medications Total Testosterone &gt;58 ng/dl or bioavailable
        testosterone &gt;15 ng/dl Prolactin &lt;25 ng/ml Baseline 17-OHP &lt;3 ng/ml (and stimulated 17-OHP
        &lt;10 ng/ml if subject is studied on-site)

        Control women who meet the following criteria will be enrolled:

        History of completely regular menstrual cycles. No history of hirsutism or alopecia.
        Control women will have a blood sample obtained 3-6 months after they have stopped
        lactating and resumed regular menses to ensure that they have normal T, uT and DHEAS
        levels.

        Any pregnant woman who develops gestational diabetes will be excluded from the analysis.

        To exclude disorders associated with insulin resistance, control subjects will have no
        personal history of hypertension or hypertriglyceridemia and no first-degree relative with
        Type 2 DM

        Exclusion Criteria:

          -  history of gestational diabetes mellitus, eclampsia, pre-eclampsia or any medical
             disorders complicating their pregnancies.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrea E Dunaif, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chief, Division of Endocrinology, Metabolism and Molecular Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Northwestern University School of Medicine</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.pcos.northwestern.edu/</url>
    <description>Northwestern University PCOS Study Website</description>
  </link>
  <verification_date>April 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 15, 2006</study_first_submitted>
  <study_first_submitted_qc>August 15, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 16, 2006</study_first_posted>
  <results_first_submitted>July 19, 2010</results_first_submitted>
  <results_first_submitted_qc>July 19, 2010</results_first_submitted_qc>
  <results_first_posted type="Estimate">August 18, 2010</results_first_posted>
  <last_update_submitted>April 3, 2013</last_update_submitted>
  <last_update_submitted_qc>April 3, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 10, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)</investigator_affiliation>
    <investigator_full_name>Andrea Dunaif</investigator_full_name>
    <investigator_title>Charles F Kettering Professor of Endocrinology &amp; Metabolism Vice Chair for Research, Department of Medicine</investigator_title>
  </responsible_party>
  <keyword>Polycystic Ovary Syndrome</keyword>
  <keyword>PCOS</keyword>
  <keyword>Pregnant</keyword>
  <keyword>Cord Blood</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Polycystic Ovary Syndrome</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>letters to participants from other studies and patients from Ob/Gyn at Northwestern</recruitment_details>
      <pre_assignment_details>Exclusion based on personal/family history of diabetes or pre-existing medical condition</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Control</title>
          <description>Control</description>
        </group>
        <group group_id="P2">
          <title>PCOS</title>
          <description>Polycystic Ovary Syndrome</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="31"/>
                <participants group_id="P2" count="39"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="31"/>
                <participants group_id="P2" count="39"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Control</title>
          <description>Control</description>
        </group>
        <group group_id="B2">
          <title>PCOS</title>
          <description>Polycystic Ovary Syndrome</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="31"/>
            <count group_id="B2" value="39"/>
            <count group_id="B3" value="70"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="31"/>
                    <measurement group_id="B2" value="39"/>
                    <measurement group_id="B3" value="70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="31"/>
                    <measurement group_id="B2" value="39"/>
                    <measurement group_id="B3" value="70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="31"/>
                    <measurement group_id="B2" value="39"/>
                    <measurement group_id="B3" value="70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Pre-pregnancy BMI</title>
          <units>kg/&quot;m^2&quot;</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25.1" spread="5.7"/>
                    <measurement group_id="B2" value="30.8" spread="8.9"/>
                    <measurement group_id="B3" value="28.3" spread="7.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Maternal age at delivery</title>
          <units>yr</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="32.4" spread="4.4"/>
                    <measurement group_id="B2" value="30.1" spread="3.9"/>
                    <measurement group_id="B3" value="31.1" spread="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Estradiol Level in Female Offspring</title>
        <description>The blood that were analyzed were taken from cord blood and not from the offspring.</description>
        <time_frame>One time sampling from the cord blood</time_frame>
        <population>The number of the participants analyzed only included the levels for the female offspring.</population>
        <group_list>
          <group group_id="O1">
            <title>Control</title>
            <description>Control</description>
          </group>
          <group group_id="O2">
            <title>PCOS</title>
            <description>Polycystic Ovary Syndrome</description>
          </group>
        </group_list>
        <measure>
          <title>Estradiol Level in Female Offspring</title>
          <description>The blood that were analyzed were taken from cord blood and not from the offspring.</description>
          <population>The number of the participants analyzed only included the levels for the female offspring.</population>
          <units>pg/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18606" spread="18845"/>
                    <measurement group_id="O2" value="6467" spread="3989"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.049</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Androstenedione Level in Female Offspring</title>
        <time_frame>cord blood</time_frame>
        <population>The number of participants analyzed only included the levels of the female offspring.</population>
        <group_list>
          <group group_id="O1">
            <title>Control</title>
            <description>Control</description>
          </group>
          <group group_id="O2">
            <title>PCOS</title>
            <description>Polycystic Ovary Syndrome</description>
          </group>
        </group_list>
        <measure>
          <title>Androstenedione Level in Female Offspring</title>
          <population>The number of participants analyzed only included the levels of the female offspring.</population>
          <units>ng/dl</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="146" spread="104"/>
                    <measurement group_id="O2" value="87" spread="46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.042</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Testosterone Level in Female Offspring</title>
        <time_frame>cord blood</time_frame>
        <population>The number of participants analyzed only included the levels of the female offspring.</population>
        <group_list>
          <group group_id="O1">
            <title>Control</title>
            <description>Control</description>
          </group>
          <group group_id="O2">
            <title>PCOS</title>
            <description>Polycystic Ovary Syndrome</description>
          </group>
        </group_list>
        <measure>
          <title>Testosterone Level in Female Offspring</title>
          <population>The number of participants analyzed only included the levels of the female offspring.</population>
          <units>ng/dl</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19" spread="29"/>
                    <measurement group_id="O2" value="7" spread="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.156</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>17-hydroxyprogesterone Level in Female Offspring</title>
        <time_frame>cord blood</time_frame>
        <population>The number of participants analyzed only included the levels of the female offspring.</population>
        <group_list>
          <group group_id="O1">
            <title>Control</title>
            <description>Control</description>
          </group>
          <group group_id="O2">
            <title>PCOS</title>
            <description>Polycystic Ovary Syndrome</description>
          </group>
        </group_list>
        <measure>
          <title>17-hydroxyprogesterone Level in Female Offspring</title>
          <population>The number of participants analyzed only included the levels of the female offspring.</population>
          <units>ng/dl</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2990" spread="1883"/>
                    <measurement group_id="O2" value="2777" spread="2103"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.770</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Dihydrotestosterone Level in Female Offspring</title>
        <time_frame>cord blood</time_frame>
        <population>The number of participants analyzed only included the levels of the female offspring.</population>
        <group_list>
          <group group_id="O1">
            <title>Control</title>
            <description>Control</description>
          </group>
          <group group_id="O2">
            <title>PCOS</title>
            <description>Polycystic Ovary Syndrome</description>
          </group>
        </group_list>
        <measure>
          <title>Dihydrotestosterone Level in Female Offspring</title>
          <population>The number of participants analyzed only included the levels of the female offspring.</population>
          <units>pg/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88" spread="75"/>
                    <measurement group_id="O2" value="137" spread="162"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.325</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Dehydroepiandrosterone Level in Female Offspring</title>
        <time_frame>cord blood</time_frame>
        <population>The number of participants analyzed only included the levels of the female offspring.</population>
        <group_list>
          <group group_id="O1">
            <title>Control</title>
            <description>Control</description>
          </group>
          <group group_id="O2">
            <title>PCOS</title>
            <description>Polycystic Ovary Syndrome</description>
          </group>
        </group_list>
        <measure>
          <title>Dehydroepiandrosterone Level in Female Offspring</title>
          <population>The number of participants analyzed only included the levels of the female offspring.</population>
          <units>ng/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5" spread="4"/>
                    <measurement group_id="O2" value="3" spread="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Infant Birth Weight (Male and Female)</title>
        <time_frame>birth</time_frame>
        <population>Birth weight of the male and female infants.</population>
        <group_list>
          <group group_id="O1">
            <title>Control</title>
            <description>Control</description>
          </group>
          <group group_id="O2">
            <title>PCOS</title>
            <description>Polycystic Ovary Syndrome</description>
          </group>
        </group_list>
        <measure>
          <title>Infant Birth Weight (Male and Female)</title>
          <population>Birth weight of the male and female infants.</population>
          <units>gram</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
                <count group_id="O2" value="39"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3571" spread="389"/>
                    <measurement group_id="O2" value="3539" spread="597"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <desc>Serious and/or other (non-serious) adverse events were not assessed or collected because the cord blood sampling after the delivery of the offspring did not put anybody at risk.</desc>
      <group_list>
        <group group_id="E1">
          <title>Control</title>
          <description>Control</description>
        </group>
        <group group_id="E2">
          <title>PCOS</title>
          <description>Polycystic Ovary Syndrome</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="39"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="39"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Andrea Dunaif</name_or_title>
      <organization>Northwestern University</organization>
      <phone>312-503-2902</phone>
      <email>a-dunaif@northwestern.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

